scispace - formally typeset
N

Naohiko Seki

Researcher at Chiba University

Publications -  391
Citations -  20245

Naohiko Seki is an academic researcher from Chiba University. The author has contributed to research in topics: microRNA & Cancer. The author has an hindex of 74, co-authored 381 publications receiving 18648 citations. Previous affiliations of Naohiko Seki include Toho University & National Institute of Radiological Sciences.

Papers
More filters
Journal ArticleDOI

MicroRNA-874 targets phosphomevalonate kinase and inhibits cancer cell growth via the mevalonate pathway

TL;DR: In this paper , the authors showed that miR-874-induced apoptosis was p53 dependent, and single-cell RNA sequencing analysis demonstrated that miRNA transfection resulted in apoptosis and p53 pathway activation, which was rescued by geranylgeranyl pyrophosphate (GGPP) supplementation.
Book ChapterDOI

DNA Methylation and Dysregulation of miRNA in Cancer

TL;DR: Dysregulated expression of miRNAs can disrupt tightly regulated RNA networks in cancer cells, and their dysregulation has been observed in several human diseases, including cancers.
Journal ArticleDOI

Inhibition of Cell Growth by Nuclear Receptor COUP-TFI: Possible Involvementof Decorin in Growth Inhibition

TL;DR: Flow cytometric analysis showed that progression through mid-S to G2/M phase was delayed in COUP-TFI transfectants, and Luciferase reporter assay revealed that decorin transactivated by COUP -TFI is one of the molecules which account for the growthinhibitory effects of COUPTFI.
Journal ArticleDOI

461 microrna-29 family as tumor suppressive micrornas in renal cell carcinoma: microrna-29a inhibits cell migration and invasion targeting focal adhesion and ecm pathways

TL;DR: The data are the first to validate metabolomics as applied to renal cancer and demonstrate significant changes in the transcriptional profile of ccRCC at the levels of glycolysis, gluconeogenesis, and oxidative phosphorylation consistent with a glygolytic phenotype.